Survivin
Survivin is a member of the inhibitor of
apoptosis family of proteins and functions to inhibit
apoptosis and promote cell division.Survivin expression is developmentally regulated in normal tissue, with little expression in most terminally differentiated tissues. The abnormally high expression of
survivin in
cancer cells makes it an attractive anticancer target. However, accumulating evidence indicates potential functions for
survivin in normal tissues, indicating that
survivin expression is not
cancer specific. Interestingly,
survivin expression is upregulated by adipokines such as leptin, suggesting that the molecular effects of
adiposity on
carcinogenesis might be mediated by suppression of
apoptosis through survivindependent mechanisms. Moreover, it has been demonstrated that
survivin is regulated by cytokines in lymphocytes and plays an important role in proliferation and survival of
hematopoietic cells. To our knowledge, no studies have examined the impact of
obesity on
survivin expression. We hypothesized that an obese
environment could promote survival of the ASC niche by decreasing its sensitivity to
apoptosis via a survivindependent mechanism. We show for the first time that circulating levels and WAT expression of
survivin are increased in human obesity. Furthermore, we demonstrate that
survivin protein expression is elevated in ASCs isolated from obese individuals, and protects from apoptosis. These findings outline a regulatory for
survivin as a new player in AT remodeling with potential impact in the mechanisms linking obesity/adiposity to increased
cancer risk.
High Impact List of Articles
-
Acknowledgements: Volume 7 Issue 6
Appendices: Clinical Practice
-
Acknowledgements: Volume 7 Issue 6
Appendices: Clinical Practice
-
Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study
Vivencio Barrios, Carlos Escobar, Juan Antonio Divison and Francisco Medialdea
Research Article: Clinical Practice
-
Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study
Vivencio Barrios, Carlos Escobar, Juan Antonio Divison and Francisco Medialdea
Research Article: Clinical Practice
-
Decoy oligonucleotides: silencing the negativity in gene therapy?
N Nogoy
Perspective: Clinical Practice
-
Decoy oligonucleotides: silencing the negativity in gene therapy?
N Nogoy
Perspective: Clinical Practice
-
Bilateral angle-closure glaucoma secondary to selective serotonin reuptake inhibitor
Peter Cackett, JR Cameron, B Morris, E Scoppettuolo and J Singh
Case Report: Clinical Practice
-
Bilateral angle-closure glaucoma secondary to selective serotonin reuptake inhibitor
Peter Cackett, JR Cameron, B Morris, E Scoppettuolo and J Singh
Case Report: Clinical Practice
-
Botulinum toxin type A for treatment of hyperhidrosis
Lisa Nelson
Review Article: Clinical Practice
-
Botulinum toxin type A for treatment of hyperhidrosis
Lisa Nelson
Review Article: Clinical Practice
Relevant Topics in Clinical